November 12, 2001
Buckton Scott, Guanghan Zhenghua Biochem Form Joint Venture
FAIRFIELD, N.J.--The Buckton Scott Group(www.buckton.com) formed a joint venture with Guanghan Zhenghua Biochem Factory to produce chondroitin sulfate. The new company, Buckton Scott Group Zhenghua Pharmaceutical Co. Ltd., is the second joint venture for the Buckton Scott Group for manufacturing chondroitin sulfate. The first is Buckton Scott Group Gongan Lijing Biochem Factory.In addition to its investments in chondroitin sulfate products, Buckton Scott formed a joint venture company known as Buckton Scott Group Aoxing Chitin Co. Ltd. with a capacity of 800 metric tons per year for sulfate and HCL product forms. Buckton Scott has traded with China for more than 30 years, and noted that its worldwide sales offices have direct interaction with its Wuhan, China, office and the factories in China.For more information, visit Booth #1351-1353 at SupplySide West.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023